Global T-Cell Immunotherapy Market Report, Production, Consumption and Forecast 2015-2026

Summary

This report researches the worldwide T-Cell Immunotherapy market size (value) in key regions like United States, Europe, China, Japan and other regions.

This study categorizes the global T-Cell Immunotherapy breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks, sales channels, distributors.

Global T-Cell Immunotherapy market size will increase to xx million US$ by 2026, from xx million US$ in 2019, growing at a CAGR of xx% during 2020-2026.

Global Major Manufacturers of T-Cell Immunotherapy Breakdown Data, including:

Adaptimmune

Altor Bioscience Corporation

Cellectis

Juno Therapeutics

Kite Pharma

Novartis

Takara Bio

Unum Therapeutics

Global Sales Breakdown Data of T-Cell Immunotherapy by Type basis, including:

CAR-T

TCR

TIL Therapies

Global Consumption Breakdown Data of T-Cell Immunotherapy by Application, including:

Stomach Cancer

Lung Cancer

Colorectal Cancer

Esophagus Cancer

Pancreatic Cancer

Others

Global T-Cell Immunotherapy Consumption Breakdown Data by Region, including:

North America (United States, Canada, Mexico

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, Australia, China Taiwan, Rest of Asia-Pacific)

Europe (Germany, UK, France, Italy, Russia, Spain, Benelux, Rest of Europe)

South America (Brazil, Argentina, Colombia, Chile, Rest of South America)

Middle East & Africa (Saudi Arabia, Turkey, Egypt, South Africa, Rest of Middle East & Africa)

Reporting Period

Historial Year 2015-2019

Base Year 2019

Estimated Year 2020E

Forecast Year 2021F-2026F

Chapters Follows:

Chapter 1: T-Cell Immunotherapy product scope, industry environment, market trends, market influence factor and market risks, marketing strategy to increase market position.

Chapter 2: T-Cell Immunotherapy competitive situation, and position in the world.

Chapter 3: The top player of T-Cell Immunotherapy market size and global market share of T-Cell Immunotherapy from 2018 to 2020.

Chapter 4: Global T-Cell Immunotherapy consumption by Region, with market size, key players, type application and major counties.

Chapter 5: Global T-Cell Immunotherapy production by Region, with market size, import & export.

Chapter 6: T-Cell Immunotherapy breakdown data by type, from 2015 to 2020.

Chapter 7: T-Cell Immunotherapy breakdown data by application, from 2015 to 2020 and downstream customers analysis.

Chapter 8: T-Cell Immunotherapy market dynamics and channel analysis.

Chapter 9: T-Cell Immunotherapy market forecast, by regions (production and consumption), type and application, from 2020 to 2026.

Chapter 10: T-Cell Immunotherapy research findings and conclusion.

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Contents

1 Market Overview

1.1 T-Cell Immunotherapy Product Introduction (Definition, Market Development & History, Type)

1.1.1 T-Cell Immunotherapy Definition

1.1.2 T-Cell Immunotherapy Market Development & History

1.1.3 T-Cell Immunotherapy Type

1.1.3.1 CAR-T

1.1.3.2 TCR

1.1.3.3 TIL Therapies

1.2 T-Cell Immunotherapy Segment by Application and Downstream Consumers

1.3 Industry Environment

1.3.1 Policy Environment

1.3.2 Economics Environment

1.3.3 Sociology Environment

1.3.4 Technology

1.3.5 Similar Industries Market Status

1.3.6 Major Regions Development Status

1.3.7 Industry News Analysis

1.4 Market Trends

1.5 Market Influence Factor

1.6 Marketing Strategy

1.7 Investment Opportunity

1.7.1 Industry Investment Opportunity

1.7.2 Regional Investment Opportunity

1.7.3 Risk Analysis

1.8 The COVID-19 Impact

1.8.1 The COVID-19 Impact Assessment

1.8.2 Market Trends from The COVID-19 Impact

1.9 T-Cell Immunotherapy SWOT Analysis

2 Market Size by Players

2.1 Global T-Cell Immunotherapy Sales by Key Players

2.2 Global T-Cell Immunotherapy Revenue by Key Players

2.3 Global T-Cell Immunotherapy Price by Key Players

2.4 Global T-Cell Immunotherapy Gross Margin by Key Players

2.5 Market Competition Analysis

2.5.1. Market Concentration Rate and Trend Analysis

2.5.2 Potential Entrants Threat

2.6 Mergers & Acquisitions, Expansion Plan

2.7 Global T-Cell Immunotherapy Position in the World in by Key Players

3 T-Cell Immunotherapy Major Manufactures Profile

3.1 Adaptimmune

3.1.1 Basic Information

3.1.2 Sales, Revenue, Price, Gross Margin and Global Share

3.1.3 Business Region Distribution

3.2 Altor Bioscience Corporation

3.2.1 Basic Information

3.2.2 Sales, Revenue, Price, Gross Margin and Global Share

3.2.3 Recent Developments

3.3 Cellectis

3.3.1 Basic Information

3.3.2 Sales, Revenue, Price, Gross Margin and Global Share

3.3.3 Business Region Distribution

3.4 Juno Therapeutics

3.4.1 Basic Information

3.4.2 Sales, Revenue, Price, Gross Margin and Global Share

3.4.3 Business Region Distribution

3.5 Kite Pharma

3.5.1 Basic Information

3.5.2 Sales, Revenue, Price, Gross Margin and Global Share

3.5.3 Business Region Distribution

3.6 Novartis

3.6.1 Basic Information

3.6.2 Sales, Revenue, Price, Gross Margin and Global Share

3.6.3 Business Region Distribution

3.7 Takara Bio

3.7.1 Basic Information

3.7.2 Sales, Revenue, Price, Gross Margin and Global Share

3.7.3 Business Region Distribution

3.8 Unum Therapeutics

3.8.1 Basic Information

3.8.2 Sales, Revenue, Price, Gross Margin and Global Share

3.8.3 Business Region Distribution

4 Consumption by Region

4.1 North America T-Cell Immunotherapy Market Analysis

4.1.1 North America T-Cell Immunotherapy Sales Volume

4.1.2 North America T-Cell Immunotherapy Revenue

4.1.3 Key Players in North America

4.1.4 North America T-Cell Immunotherapy Market Size by Type

4.1.5 North America T-Cell Immunotherapy Market Size by Applications

4.1.6 North America T-Cell Immunotherapy Market Size by Countries

4.2 Europe T-Cell Immunotherapy Market Analysis

4.2.1 Europe T-Cell Immunotherapy Sales Volume

4.2.2 Europe T-Cell Immunotherapy Revenue

4.2.3 Key Players in Europe

4.2.4 Europe T-Cell Immunotherapy Market Size by Type

4.2.5 Europe T-Cell Immunotherapy Market Size by Applications

4.2.6 Europe T-Cell Immunotherapy Market Size by Countries

4.3 Asia-Pacific T-Cell Immunotherapy Market Analysis

4.3.1 Asia-Pacific T-Cell Immunotherapy Sales Volume

4.3.2 Asia-Pacific T-Cell Immunotherapy Revenue

4.3.3 Key Players in Asia-Pacific

4.3.4 Asia-Pacific T-Cell Immunotherapy Market Size by Type

4.3.5 Asia-Pacific T-Cell Immunotherapy Market Size by Applications

4.3.6 Asia-Pacific T-Cell Immunotherapy Market Size by Countries

4.4 Central & South America T-Cell Immunotherapy Market Analysis

4.4.1 Central & South America T-Cell Immunotherapy Sales Volume

4.4.2 Central & South America T-Cell Immunotherapy Revenue

4.4.3 Key Players in Central & South America

4.4.4 Central & South America T-Cell Immunotherapy Market Size by Type

4.4.5 Central & South America T-Cell Immunotherapy Market Size by Applications

4.4.6 Central & South America T-Cell Immunotherapy Market Size by Countries

4.5 Middle East & Africa T-Cell Immunotherapy Market Analysis

4.5.1 Middle East & Africa T-Cell Immunotherapy Sales Volume

4.5.2 Middle East & Africa T-Cell Immunotherapy Revenue

4.5.3 Key Players in Middle East & Africa

4.5.4 Middle East & Africa T-Cell Immunotherapy Market Size by Type

4.5.5 Middle East & Africa T-Cell Immunotherapy Market Size by Applications

4.5.6 Middle East & Africa T-Cell Immunotherapy Market Size by Countries

5 Production by Regions

5.1 Global T-Cell Immunotherapy Production (History Data) by Regions 2015-2020E

5.2 United States

5.2.1 United States T-Cell Immunotherapy Production Volume Growth Rate 2015-2020E

5.2.2 United States T-Cell Immunotherapy Import & Export

5.3 Europe

5.3.1 Europe T-Cell Immunotherapy Production Volume Growth Rate 2015-2020E

5.3.2 Europe T-Cell Immunotherapy Import & Export

5.4 China

5.4.1 China T-Cell Immunotherapy Production Volume Growth Rate 2015-2020E

5.4.2 China T-Cell Immunotherapy Import & Export

5.5 Japan

5.5.1 Japan T-Cell Immunotherapy Production Volume Growth Rate 2015-2020E

5.5.2 Japan T-Cell Immunotherapy Import & Export

5.6 Other Regions

5.6.1 Korea

5.6.2 India

5.6.3 Southeast Asia

6 Market Size by Type

6.1 Global T-Cell Immunotherapy Sales by Type

6.2 Global T-Cell Immunotherapy Revenue by Type

6.3 Global T-Cell Immunotherapy Price by Type

7 Market Size by Application

7.1 Global Market Size by Application

7.2 Downstream Customers Analysis

7.2.1 Price Factor

7.2.2 Products Quality Factor

7.2.3 Social Factors

7.2.4 Special Needs Factor

8 Market Dynamics and Channel Analysis

8.1 Market Dynamics

8.1.1 Market Capacity Analysis

8.1.2 Market Drivers and Influence Factors

8.1.3 Market Challenges

8.1.4 Porter's Five Forces Analysis

8.2 Channel Analysis

8.2.1 Sales Channel

8.2.2 Distributors

9 Market Forecast

9.1 T-Cell Immunotherapy Consumption Forecast by Region

9.1.1 Global T-Cell Immunotherapy Market Forecast by Region

9.1.2 North America T-Cell Immunotherapy Market Forecast by Countries

9.1.3 Europe T-Cell Immunotherapy Market Forecast by Countries

9.1.4 Asia-Pacific T-Cell Immunotherapy Market Forecast by Countries

9.1.5 Central & South America T-Cell Immunotherapy Market Forecast by Countries

9.1.6 Middle East & Africa T-Cell Immunotherapy Market Forecast by Countries

9.2 T-Cell Immunotherapy Production Forecast by Region

9.3 T-Cell Immunotherapy Market Forecast by Type

9.3.1 Global T-Cell Immunotherapy Sales Forecast by Type

9.3.2 Global T-Cell Immunotherapy Revenue Forecast by Type

9.4 T-Cell Immunotherapy Market Forecast by Application

9.4.1 Global T-Cell Immunotherapy Sales Forecast by Application

9.4.2 Global T-Cell Immunotherapy Market Share Forecast by Application

10 Research Findings and Conclusion

11 Research Methodology and Data Source

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Source

11.2.2 Primary Source

If you have any special requirements, please let us know and we will offer you the report as you want.

Fact & Figures

Table T-Cell Immunotherapy Segment Introduction by Application

Table Global T-Cell Immunotherapy Market Revenue (Million USD) Before and After COVID-19

Table Market Trends from The COVID-19 Impact

Table Global T-Cell Immunotherapy Sales (Volume) by Key Players, 2018-2020E

Table Global T-Cell Immunotherapy Revenue (M USD) by Key Players, 2018-2020E

Table Global T-Cell Immunotherapy Price (USD/Volume) by Key Players, 2018-2020E

Table Global T-Cell Immunotherapy Gross Margin by Key Players, 2018-2020E

Table Mergers & Acquisitions

Table Expansion Plan by Players

Table Adaptimmune Overview List

Table T-Cell Immunotherapy Business Operation of Adaptimmune (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Altor Bioscience Corporation Overview List

Table T-Cell Immunotherapy Business Operation of Altor Bioscience Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cellectis Overview List

Table T-Cell Immunotherapy Business Operation of Cellectis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Juno Therapeutics Overview List

Table T-Cell Immunotherapy Business Operation of Juno Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Kite Pharma Overview List

Table T-Cell Immunotherapy Business Operation of Kite Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table T-Cell Immunotherapy Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Takara Bio Overview List

Table T-Cell Immunotherapy Business Operation of Takara Bio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Unum Therapeutics Overview List

Table T-Cell Immunotherapy Business Operation of Unum Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table North America T-Cell Immunotherapy Sales Volume (Volume) by Type, 2015-2020E

Table North America T-Cell Immunotherapy Revenue (M USD) by Type, 2015-2020E

Table North America T-Cell Immunotherapy Sales Volume (Volume) by Applications, 2015-2020E

Table North America T-Cell Immunotherapy Sales Volume (Volume) by Countries, 2015-2020E

Table North America T-Cell Immunotherapy Revenue (M USD) by Countries, 2015-2020E

Table Europe T-Cell Immunotherapy Sales Volume (Volume) by Type, 2015-2020E

Table Europe T-Cell Immunotherapy Revenue (M USD) by Type, 2015-2020E

Table Europe T-Cell Immunotherapy Sales Volume (Volume) by Applications, 2015-2020E

Table Europe T-Cell Immunotherapy Sales Volume (Volume) by Countries, 2015-2020E

Table Europe T-Cell Immunotherapy Revenue (M USD) by Countries, 2015-2020E

Table Asia-Pacific T-Cell Immunotherapy Sales Volume (Volume) by Type, 2015-2020E

Table Asia-Pacific T-Cell Immunotherapy Revenue (M USD) by Type, 2015-2020E

Table Asia-Pacific T-Cell Immunotherapy Sales Volume (Volume) by Applications, 2015-2020E

Table Asia-Pacific T-Cell Immunotherapy Sales Volume (Volume) by Countries, 2015-2020E

Table Asia-Pacific T-Cell Immunotherapy Revenue (M USD) by Countries, 2015-2020E

Table Central & South America T-Cell Immunotherapy Sales Volume (Volume) by Type, 2015-2020E

Table Central & South America T-Cell Immunotherapy Revenue (M USD) by Type, 2015-2020E

Table Central & South America T-Cell Immunotherapy Sales Volume (Volume) by Applications, 2015-2020E

Table Central & South America T-Cell Immunotherapy Sales Volume (Volume) by Countries, 2015-2020E

Table Central & South America T-Cell Immunotherapy Revenue (M USD) by Countries, 2015-2020E

Table Middle East & Africa T-Cell Immunotherapy Sales Volume (Volume) by Type, 2015-2020E

Table Middle East & Africa T-Cell Immunotherapy Revenue (M USD) by Type, 2015-2020E

Table Middle East & Africa T-Cell Immunotherapy Sales Volume (Volume) by Applications, 2015-2020E

Table Middle East & Africa T-Cell Immunotherapy Sales Volume (Volume) by Countries, 2015-2020E

Table Middle East & Africa T-Cell Immunotherapy Revenue (M USD) by Countries, 2015-2020E

Table Global T-Cell Immunotherapy Production Volume (Volume) by Regions, 2015-2020E

Table United States T-Cell Immunotherapy Import & Export (Volume)

Table China T-Cell Immunotherapy Import & Export (Volume)

Table China T-Cell Immunotherapy Import & Export (Volume)

Table Japan T-Cell Immunotherapy Import & Export (Volume)

Table Global T-Cell Immunotherapy Sales (Volume) by Type, 2015-2020E

Table Global T-Cell Immunotherapy Revenue (M USD) by Type, 2015-2020E

Table Global T-Cell Immunotherapy Price by Type, 2015-2020E

Table Global T-Cell Immunotherapy Sales (Volume) by Applications, 2015-2020E

Table Distributors List

Table Global T-Cell Immunotherapy Sales Volume (Volume) by Region, 2020-2026

Table Global T-Cell Immunotherapy Revenue (M USD) by Region, 2020-2026

Table North America T-Cell Immunotherapy Sales Volume (Volume) by Countries, 2020-2026

Table North America T-Cell Immunotherapy Revenue (M USD) by Countries, 2020-2026

Table Europe T-Cell Immunotherapy Sales Volume (Volume) by Countries, 2020-2026

Table Europe T-Cell Immunotherapy Revenue (M USD) by Countries, 2020-2026

Table Asia-Pacific T-Cell Immunotherapy Sales Volume (Volume) by Countries, 2020-2026

Table Asia-Pacific T-Cell Immunotherapy Revenue (M USD) by Countries, 2020-2026

Table Central & South America T-Cell Immunotherapy Sales Volume (Volume) by Countries, 2020-2026

Table Central & South America T-Cell Immunotherapy Revenue (M USD) by Countries, 2020-2026

Table Middle East & Africa T-Cell Immunotherapy Sales Volume (Volume) by Countries, 2020-2026

Table Middle East & Africa T-Cell Immunotherapy Revenue (M USD) by Countries, 2020-2026

Table Global T-Cell Immunotherapy Production Volume (Volume) by Region, 2020-2026

Table Global T-Cell Immunotherapy Production Share by Region, 2020-2026

Table Global T-Cell Immunotherapy Sales Volume (Volume) by Type, 2020-2026

Table Global T-Cell Immunotherapy Revenue (M USD) by Type, 2020-2026

Table Global T-Cell Immunotherapy Sales Volume (Volume) by Applications, 2020-2026

Table Global T-Cell Immunotherapy Sales Volume Share by Applications, 2020-2026

Table Part of Secondary Data Source List

Table Part of Interviewees Record List

If you have any special requirements, please let us know and we will offer you the report as you want.

Please share youre basic details, to recieve the report sample

If you have any special requirements, please let us know and we will offer you the report as you want.

Price Details

Single User License $ 3500

Multiple User License $ 5250

Corporate User License $ 7000

Report Details

Published By: IRRC

Published On: Apr 2021

Total Pages: 166 Pages

Category: Medical Care
Customize Purchase Options

   Buy sections of this report

   Buy country level reports

   Request for historical data

   Discounts for Start-Ups & Universities

   Minimal amount for sections and chapters
Connect With Us

Have Questions ? Please contact us